Annexon Inc
ANNXHealthcare|Biotechnology|USA
$5.79
-0.14 (-2.36%)
Tangible Book
$1.26
Earnings Power
$0.88
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (85)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Satter Muneer A | Director | 2026-05-28 | BUY | 613,497 | $5.41 | $3319K |
| Carson William H. | Director | 2026-05-11 | BUY | 8,000 | $5.78 | $46.2K |
| Carson William H. | Director | 2026-04-10 | BUY | 8,000 | $6.2 | $49.6K |
| Carson William H. | Director | 2026-03-10 | BUY | 8,000 | $5.67 | $45.4K |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | 2026-03-02 | SELL | 5,820 | $5.43 | $31.6K |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | 2026-03-02 | SELL | 4,339 | $5.42 | $23.5K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2026-03-02 | SELL | 5,566 | $5.42 | $30.2K |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | 2026-03-02 | SELL | 5,894 | $5.43 | $32K |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 2026-03-02 | SELL | 5,565 | $5.42 | $30.2K |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | 2026-02-18 | SELL | 5,290 | $5.1 | $27K |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 2026-02-18 | SELL | 7,851 | $5.11 | $40.1K |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | 2026-02-18 | SELL | 5,290 | $5.1 | $27K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2026-02-18 | SELL | 7,857 | $5.11 | $40.1K |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | 2026-02-18 | SELL | 6,225 | $5.1 | $31.7K |
| Carson William H. | Director | 2025-12-30 | BUY | 4,115 | $5.02 | $20.7K |
| Carson William H. | Director | 2025-12-01 | BUY | 4,115 | $4.47 | $18.4K |
| Choi Jung | Director | 2025-12-01 | BUY | 33,000 | $4.19 | $138.3K |
| Satter Muneer A | Director | 2025-11-21 | BUY | 822,613 | $4.38 | $3603K |
| Satter Muneer A | Director | 2025-11-19 | BUY | 1,500,000 | $3.37 | $5055K |
| Carson William H. | Director | 2025-10-30 | BUY | 4,115 | $3.17 | $13K |
| Carson William H. | Director | 2025-09-30 | BUY | 4,115 | $3.05 | $12.6K |
| Carson William H. | Director | 2025-09-02 | BUY | 4,115 | $2.09 | $8.6K |
| Carson William H. | Director | 2025-07-30 | BUY | 4,115 | $2.43 | $10K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2025-07-14 | SELL | 1,116 | $2.58 | $2.9K |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 2025-07-14 | SELL | 1,117 | $2.58 | $2.9K |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | 2025-07-14 | SELL | 853 | $2.61 | $2.2K |
| Carson William H. | Director | 2025-06-30 | BUY | 4,115 | $2.46 | $10.1K |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | 2025-02-18 | SELL | 5,521 | $2.96 | $16.3K |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | 2025-02-18 | SELL | 6,618 | $2.95 | $19.5K |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 2025-02-18 | SELL | 6,912 | $2.92 | $20.2K |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | 2025-02-18 | SELL | 5,515 | $2.97 | $16.4K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2025-02-18 | SELL | 8,345 | $2.91 | $24.3K |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | 2025-02-13 | SELL | 1,425 | $2.99 | $4.3K |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 2025-02-13 | SELL | 1,786 | $2.98 | $5.3K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2025-02-13 | SELL | 1,783 | $2.99 | $5.3K |
| Love Douglas | PRESIDENT AND CEO | 2025-02-13 | SELL | 5,021 | $2.95 | $14.8K |
| Carson William H. | Director | 2024-12-02 | BUY | 3,200 | $5.33 | $17.1K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2024-10-15 | SELL | 5,408 | $7.41 | $40.1K |
| Carson William H. | Director | 2024-10-01 | BUY | 3,200 | $5.97 | $19.1K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2024-09-19 | SELL | 4,500 | $7.1 | $32K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2024-09-12 | SELL | 5,500 | $6.16 | $33.9K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2024-09-05 | SELL | 5,500 | $5.64 | $31K |
| Carson William H. | Director | 2024-09-03 | BUY | 3,200 | $5.48 | $17.5K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2024-08-29 | SELL | 5,500 | $5.95 | $32.7K |
| Carson William H. | Director | 2024-08-01 | BUY | 3,200 | $6.24 | $20K |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | 2024-07-15 | SELL | 784 | $6.02 | $4.7K |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 2024-07-15 | SELL | 1,104 | $6.03 | $6.7K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2024-07-15 | SELL | 1,106 | $6.02 | $6.7K |
| Carson William H. | Director | 2024-07-01 | BUY | 3,200 | $5 | $16K |
| Carson William H. | Director | 2024-06-03 | BUY | 3,200 | $4.83 | $15.5K |
| Carson William H. | Director | 2024-05-01 | BUY | 3,200 | $4.68 | $15K |
| Carson William H. | Director | 2024-04-08 | BUY | 3,200 | $6.07 | $19.4K |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 2024-02-20 | SELL | 2,593 | $5.53 | $14.3K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2024-02-20 | SELL | 2,604 | $5.51 | $14.3K |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | 2024-02-20 | SELL | 1,951 | $5.48 | $10.7K |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | 2024-02-12 | SELL | 1,349 | $5.53 | $7.5K |
| Love Douglas | PRESIDENT AND CEO | 2024-02-12 | SELL | 5,782 | $5.54 | $32K |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 2024-02-12 | SELL | 1,809 | $5.54 | $10K |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2024-02-12 | SELL | 1,810 | $5.54 | $10K |
| Yednock Ted | EVP & Chief Innovation Officer | 2023-12-27 | SELL | 22,057 | $4.49 | $99K |
| Yednock Ted | EVP & Chief Innovation Officer | 2023-12-27 | SELL | 21,000 | $4.52 | $94.9K |
| Satter Muneer A | Director, 10% Owner | 2023-12-26 | BUY | 350,000 | $2.88 | $1008K |
| Overdorf Michael | EVP & Chief Business Officer | 2023-07-11 | SELL | 978 | $3.84 | $3.8K |
| Lew Jennifer | EVP & CFO | 2023-07-11 | SELL | 1,057 | $3.84 | $4.1K |
| Bain Capital Life Sciences Fund, L.P. | 10% Owner | 2023-05-25 | BUY | 300,000 | $2.13 | $639K |
| Love Douglas | President & CEO | 2023-02-15 | SELL | 6,571 | $5.87 | $38.6K |
| Overdorf Michael | EVP & Chief Business Officer | 2023-02-14 | SELL | 1,645 | $6.3 | $10.4K |
| Lew Jennifer | EVP & CFO | 2023-02-14 | SELL | 1,908 | $6.31 | $12K |
| Satter Muneer A | Director, 10% Owner | 2023-02-10 | BUY | 2,647,058 | $6.8 | $18000K |
| Satter Muneer A | Director | 2022-07-07 | BUY | 2,453,988 | $3.84 | $9423.3K |
| Love Douglas | President & CEO | 2022-04-14 | BUY | 60,000 | $2.45 | $147K |
| Love Douglas | President & CEO | 2021-09-16 | SELL | 7,500 | $22.05 | $165.4K |
| Yednock Ted | EVP & Chief Scientific Officer | 2021-09-13 | SELL | 16,190 | $20 | $323.8K |
| Lew Jennifer | EVP & CFO | 2021-09-13 | SELL | 3,500 | $20.01 | $70K |
| Love Douglas | President & CEO | 2021-06-08 | SELL | 7,500 | $22.43 | $168.2K |
| Love Douglas | President & CEO | 2021-04-01 | SELL | 7,602 | $28.11 | $213.7K |
| Love Douglas | President & CEO | 2021-03-30 | SELL | 7,500 | $24.97 | $187.3K |
| Yednock Ted | EVP & Chief Scientific Officer | 2021-03-25 | SELL | 16,175 | $28.8 | $465.8K |
| Keswani Sanjay | EVP & Chief Medical Officer | 2021-03-24 | SELL | 3,995 | $30.17 | $120.5K |
| Lew Jennifer | EVP & CFO | 2021-03-23 | SELL | 5,000 | $28.44 | $142.2K |
| Flynn James E | 2020-07-28 | BUY | 700,000 | $17 | $11900K | |
| Bain Capital Life Sciences Fun | 10% Owner | 2020-07-28 | BUY | 400,000 | $17 | $6800K |
| Lew Jennifer | EVP & CFO | 2020-07-28 | BUY | 2,000 | $17 | $34K |
| Satter Muneer A | Director | 2020-07-28 | BUY | 200,000 | $17 | $3400K |
| Clarus Lifesciences III, L.P. | 10% Owner | 2020-07-28 | BUY | 200,000 | $17 | $3400K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked